Posted: Apr 5, 2013 8:07 AM by AP
A Tulane University assistant professor of neuroscience and cell and molecular biology has a five-year federal grant to buy new lab equipment and hire researchers for a study of the role of a brain receptor in treating depression.
A news release says Benjamin Hall's team will study the receptor affected by the anesthetic ketamine.
Hall said Thursday that because ketamine can cause hallucinations, it's not used to treat depression, even though it can rapidly lift depression in patients who don't respond to standard drugs.
Hall says knowing just how ketamine affects the NMDA receptor could help develop antidepressants without its side effects.